Atossa Therapeutics, Inc. (ATOS) Financials

ATOS Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 101.7 million 3.4 million
2023-06-30 108.4 million 3.5 million
2023-03-31 116.2 million 2.9 million
2022-12-31 123.5 million 5.6 million

ATOS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -3.9 million 926000
2023-06-30 -4.5 million 1.6 million
2023-03-31 -7.0 million 1.6 million
2022-12-31 -4.5 million 1.5 million

ATOS Net Income

No data available :(

ATOS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 94.0 million - -
2023-06-30 99.4 million - -
2023-03-31 103.9 million - -
2022-12-31 110.9 million - -

ATOS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 125.8 million
2023-06-30 126.6 million
2023-03-31 126.6 million
2022-12-31 126.6 million

ATOS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 1000 4.5 million 3.0 million -
2023-06-30 13000 3.7 million 4.1 million -
2023-03-31 - 3.5 million 3.6 million -
2022-12-31 8000 5.0 million 3.2 million -

ATOS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 3000
2023-06-30 - 3000
2023-03-31 - 3000
2022-12-31 - 2000

ATOS

Price: $1.53

52 week price:
0.59
2.31

Earnings Per Share: -0.24 USD

P/E Ratio: -3.95

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 530800

Ebitda: -2.0 million

Market Capitalization: 221.8 million

Links: